secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2024-12-10T23:59:59+00:00
Accession:  0001472375-24-000106
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

RegeneRx Pharma announces CFO resignation and appointments of new CFO, Secretary, and board member
--------------------------------------------------------------------------------

- Deborah Pilant resigned as CFO, Secretary/Treasurer, and board director effective Dec 6, 2024, due to retirement.
- Brent Wilson appointed CFO; CPA with 30 years experience, previously at KPMG, effective Dec 6, 2024.
- Dr. Lee Ori appointed Secretary/Treasurer for the coming year; currently serves as a board director.
- J. Kenneth Hazen appointed to the board; President/CEO of CTSI-Global, recognized in logistics and supply chain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/0001472375-24-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237524000106/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-24-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer